Literature DB >> 26622632

Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer.

Kohei Kobatake1, Koji Mita1, Shinya Ohara1, Masao Kato1.   

Abstract

The aim of the present study was to compare the benefits of transurethral resection (TUR) under narrow band imaging (NBI-TUR) and TUR under conventional white light imaging (WLI-TUR) for non-muscle invasive bladder cancer (NMIBC). The study cohort consisted of 135 patients with NMIBC who were followed up for ≥1 year after TUR and who received no additional post-operative treatment. In the WLI-TUR group (n=78), systematic intravesical observation under WLI was followed by a multiple site biopsy (MSB), after which lesions detected as positive findings were resected completely under WLI. In the NBI-TUR group (n=57), similar observation under WLI was followed by systematic intravesical observation under NBI. Following MSB under NBI, TUR was performed for all lesions detected as positive findings under NBI. The sensitivity, specificity, positive-predictive value, negative-predictive value (NPV) and accuracy in the NBI-TUR group were calculated using results from the cystoscopical and pathological examinations of MSB samples under WLI and NBI. The tumor recurrence rate was analyzed in the two groups. Background factors did not differ significantly between the two groups, with the exception of the observation period (31.0 vs. 15.0 months; P<0.01). The procedure under NBI exhibited significantly higher sensitivity (95.0 vs. 70.0%; P<0.01) and NPV (97.1 vs. 86.8%; P<0.01) compared with the procedure under WLI. The 1-year recurrence rate in the NBI-TUR group was significantly lower than that in the WLI-TUR group (21.1 vs. 39.7%; P=0.016). In conclusion, the present study indicated that NBI-TUR is more advantageous than conventional WLI-TUR for patients with NMIBC.

Entities:  

Keywords:  bladder cancer; narrow band imaging; transurethral resection

Year:  2015        PMID: 26622632      PMCID: PMC4509371          DOI: 10.3892/ol.2015.3280

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  15 in total

1.  Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.

Authors:  Dmitry I Daniltchenko; Claus R Riedl; Markus D Sachs; Frank Koenig; Kurosch L Daha; Heinz Pflueger; Stefan A Loening; Dietmar Schnorr
Journal:  J Urol       Date:  2005-12       Impact factor: 7.450

2.  Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer.

Authors:  Evelyne C C Cauberg; Sarah Kloen; Mike Visser; Jean J M C H de la Rosette; Marko Babjuk; Viktor Soukup; Michael Pesl; Jaroslava Duskova; Theo M de Reijke
Journal:  Urology       Date:  2010-03-12       Impact factor: 2.649

3.  Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer.

Authors:  Katsunori Tatsugami; Kentaro Kuroiwa; Toshiyuki Kamoto; Hiroyuki Nishiyama; Jun Watanabe; Satoru Ishikawa; Nobuo Shinohara; Ataru Sazawa; Shoji Fukushima; Seiji Naito
Journal:  J Endourol       Date:  2010-08-14       Impact factor: 2.942

4.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

Authors:  Richard J Sylvester; Adrian P M van der Meijden; Willem Oosterlinck; J Alfred Witjes; Christian Bouffioux; Louis Denis; Donald W W Newling; Karlheinz Kurth
Journal:  Eur Urol       Date:  2006-01-17       Impact factor: 20.096

5.  Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder.

Authors:  Richard T Bryan; Lucinda J Billingham; D Michael A Wallace
Journal:  BJU Int       Date:  2007-11-13       Impact factor: 5.588

6.  Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies.

Authors:  Maurizio Brausi; Laurence Collette; Karlheinz Kurth; Adrian P van der Meijden; Wim Oosterlinck; J A Witjes; Donald Newling; Christian Bouffioux; Richard J Sylvester
Journal:  Eur Urol       Date:  2002-05       Impact factor: 20.096

7.  A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.

Authors:  Harry W Herr; S Machele Donat
Journal:  BJU Int       Date:  2008-09-03       Impact factor: 5.588

8.  Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.

Authors:  Martin C Schumacher; Sten Holmäng; Thomas Davidsson; Bengt Friedrich; Jörgen Pedersen; N Peter Wiklund
Journal:  Eur Urol       Date:  2009-11-06       Impact factor: 20.096

9.  Narrow band imaging for detecting residual/recurrent cancerous tissue during second transurethral resection of newly diagnosed non-muscle-invasive high-grade bladder cancer.

Authors:  Angelo Naselli; Carlo Introini; Franco Bertolotto; Bruno Spina; Paolo Puppo
Journal:  BJU Int       Date:  2009-06-22       Impact factor: 5.588

10.  Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate.

Authors:  Evelyne C C Cauberg; Charalampos Mamoulakis; Jean J M C H de la Rosette; Theo M de Reijke
Journal:  World J Urol       Date:  2011-02-25       Impact factor: 4.226

View more
  8 in total

1.  Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy.

Authors:  S Tschirdewahn; N N Harke; L Hirner; E Stagge; B Hadaschik; Andreas Eisenhardt
Journal:  World J Urol       Date:  2019-08-30       Impact factor: 4.226

Review 2.  Narrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysis.

Authors:  Weiting Kang; Zilian Cui; Qianqian Chen; Dong Zhang; Haiyang Zhang; Xunbo Jin
Journal:  Oncotarget       Date:  2017-04-04

3.  A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer.

Authors:  YiQuan Xiong; JianDong Li; ShuJuan Ma; Jing Ge; LiZhi Zhou; Dongliang Li; Qing Chen
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

4.  Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy.

Authors:  Seung Bin Kim; Sung Goo Yoon; Jonghyun Tae; Jae Yoon Kim; Ji Sung Shim; Sung Gu Kang; Jun Cheon; Jeong Gu Lee; Je Jong Kim; Seok Ho Kang
Journal:  Investig Clin Urol       Date:  2018-02-08

5.  Usefulness of narrow-band imaging in transurethral resection of bladder tumor: Early experience from a tertiary center in India.

Authors:  Kanuj Malik; Anand Raja; Sivakumar Mahalingam; L S Ravishankar
Journal:  South Asian J Cancer       Date:  2019 Oct-Dec

Review 6.  Role of Macroscopic Image Enhancement in Diagnosis of Non-Muscle-Invasive Bladder Cancer: An Analytical Review.

Authors:  Prashant Motiram Mulawkar; Gyanendra Sharma; Ashwin Tamhankar; Utsav Shah; Rickaz Raheem
Journal:  Front Surg       Date:  2022-02-21

Review 7.  Narrow band imaging for bladder cancer.

Authors:  Thomas Y Hsueh; Allen W Chiu
Journal:  Asian J Urol       Date:  2016-05-26

8.  Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.

Authors:  Changhao Chen; Hao Huang; Yue Zhao; Hao Liu; Richard Sylvester; Tianxin Lin; Jian Huang
Journal:  BMJ Open       Date:  2019-10-17       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.